The effects of self-efficacy on depression and pain in fibromyalgia syndrome: Does initial depression matter?

Charles Van Liew, Kimberly C. Brown, Terry A. Cronan, Silvia Bigatti

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Fibromyalgia syndrome [FMS] is a chronic pain condition of unknown etiology. Non-myalgic aspects of the disorder have become increasingly focal in its evaluation. Research has suggested that subgrouping FMS patients based on factors other than pain may abet diagnostic and interventional processes. Self-efficacy and depression are two such constructs that appear to be important in FMS. However, it is not known whether the consequentiality of self-efficacy in FMS is dependent on depression. The present study examined the pathways among depression, self-efficacy and pain, in a large sample of depressed and non-depressed FMS patients over a one-year timeframe to determine whether differential relationships existed. Method: Participants completed assessments of pain intensity, depression and self-efficacy at baseline, 6 months and 1 year as part of an intervention study. Approximately half of the participants met the cutoff for depression in chronic pain populations on the Centers for Epidemiologic Studies Depression Scale. Results: Participants who were depressed at baseline experienced a general decline in pain intensity and depression, whereas depression and pain for non-depressed participants appeared to be far more stable across time. Though self-efficacy was a significant predictor of changes in both pain and depression for depressed participants, self-efficacy did not predict changes in pain for non-depressed participants. Conclusion: Our findings support subgrouping FMS patients based on psychological factors. The results indicated that relationships between pain, depression and self-efficacy differed between depressed and non-depressed participants, implying that individuals with FMS and depression may benefit most from interventions that aim to decrease lability and increase self-efficacy for the most challenging times.

Original languageEnglish
Pages (from-to)113-125
Number of pages13
JournalJournal of Musculoskeletal Pain
Volume21
Issue number2
DOIs
StatePublished - Jun 2013

Fingerprint

Fibromyalgia
Self Efficacy
Depression
Pain
Chronic Pain
Pain Measurement
Epidemiologic Studies
Psychology

Keywords

  • Depression
  • Fibromyalgia
  • Longitudinal
  • Pain
  • Self-efficacy
  • Subgroups

ASJC Scopus subject areas

  • Rheumatology

Cite this

The effects of self-efficacy on depression and pain in fibromyalgia syndrome : Does initial depression matter? / Van Liew, Charles; Brown, Kimberly C.; Cronan, Terry A.; Bigatti, Silvia.

In: Journal of Musculoskeletal Pain, Vol. 21, No. 2, 06.2013, p. 113-125.

Research output: Contribution to journalArticle

@article{f68386fc339042d7be5be2a92f996f82,
title = "The effects of self-efficacy on depression and pain in fibromyalgia syndrome: Does initial depression matter?",
abstract = "Objective: Fibromyalgia syndrome [FMS] is a chronic pain condition of unknown etiology. Non-myalgic aspects of the disorder have become increasingly focal in its evaluation. Research has suggested that subgrouping FMS patients based on factors other than pain may abet diagnostic and interventional processes. Self-efficacy and depression are two such constructs that appear to be important in FMS. However, it is not known whether the consequentiality of self-efficacy in FMS is dependent on depression. The present study examined the pathways among depression, self-efficacy and pain, in a large sample of depressed and non-depressed FMS patients over a one-year timeframe to determine whether differential relationships existed. Method: Participants completed assessments of pain intensity, depression and self-efficacy at baseline, 6 months and 1 year as part of an intervention study. Approximately half of the participants met the cutoff for depression in chronic pain populations on the Centers for Epidemiologic Studies Depression Scale. Results: Participants who were depressed at baseline experienced a general decline in pain intensity and depression, whereas depression and pain for non-depressed participants appeared to be far more stable across time. Though self-efficacy was a significant predictor of changes in both pain and depression for depressed participants, self-efficacy did not predict changes in pain for non-depressed participants. Conclusion: Our findings support subgrouping FMS patients based on psychological factors. The results indicated that relationships between pain, depression and self-efficacy differed between depressed and non-depressed participants, implying that individuals with FMS and depression may benefit most from interventions that aim to decrease lability and increase self-efficacy for the most challenging times.",
keywords = "Depression, Fibromyalgia, Longitudinal, Pain, Self-efficacy, Subgroups",
author = "{Van Liew}, Charles and Brown, {Kimberly C.} and Cronan, {Terry A.} and Silvia Bigatti",
year = "2013",
month = "6",
doi = "10.3109/10582452.2013.797536",
language = "English",
volume = "21",
pages = "113--125",
journal = "Journal of Musculoskeletal Pain",
issn = "1058-2452",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - The effects of self-efficacy on depression and pain in fibromyalgia syndrome

T2 - Does initial depression matter?

AU - Van Liew, Charles

AU - Brown, Kimberly C.

AU - Cronan, Terry A.

AU - Bigatti, Silvia

PY - 2013/6

Y1 - 2013/6

N2 - Objective: Fibromyalgia syndrome [FMS] is a chronic pain condition of unknown etiology. Non-myalgic aspects of the disorder have become increasingly focal in its evaluation. Research has suggested that subgrouping FMS patients based on factors other than pain may abet diagnostic and interventional processes. Self-efficacy and depression are two such constructs that appear to be important in FMS. However, it is not known whether the consequentiality of self-efficacy in FMS is dependent on depression. The present study examined the pathways among depression, self-efficacy and pain, in a large sample of depressed and non-depressed FMS patients over a one-year timeframe to determine whether differential relationships existed. Method: Participants completed assessments of pain intensity, depression and self-efficacy at baseline, 6 months and 1 year as part of an intervention study. Approximately half of the participants met the cutoff for depression in chronic pain populations on the Centers for Epidemiologic Studies Depression Scale. Results: Participants who were depressed at baseline experienced a general decline in pain intensity and depression, whereas depression and pain for non-depressed participants appeared to be far more stable across time. Though self-efficacy was a significant predictor of changes in both pain and depression for depressed participants, self-efficacy did not predict changes in pain for non-depressed participants. Conclusion: Our findings support subgrouping FMS patients based on psychological factors. The results indicated that relationships between pain, depression and self-efficacy differed between depressed and non-depressed participants, implying that individuals with FMS and depression may benefit most from interventions that aim to decrease lability and increase self-efficacy for the most challenging times.

AB - Objective: Fibromyalgia syndrome [FMS] is a chronic pain condition of unknown etiology. Non-myalgic aspects of the disorder have become increasingly focal in its evaluation. Research has suggested that subgrouping FMS patients based on factors other than pain may abet diagnostic and interventional processes. Self-efficacy and depression are two such constructs that appear to be important in FMS. However, it is not known whether the consequentiality of self-efficacy in FMS is dependent on depression. The present study examined the pathways among depression, self-efficacy and pain, in a large sample of depressed and non-depressed FMS patients over a one-year timeframe to determine whether differential relationships existed. Method: Participants completed assessments of pain intensity, depression and self-efficacy at baseline, 6 months and 1 year as part of an intervention study. Approximately half of the participants met the cutoff for depression in chronic pain populations on the Centers for Epidemiologic Studies Depression Scale. Results: Participants who were depressed at baseline experienced a general decline in pain intensity and depression, whereas depression and pain for non-depressed participants appeared to be far more stable across time. Though self-efficacy was a significant predictor of changes in both pain and depression for depressed participants, self-efficacy did not predict changes in pain for non-depressed participants. Conclusion: Our findings support subgrouping FMS patients based on psychological factors. The results indicated that relationships between pain, depression and self-efficacy differed between depressed and non-depressed participants, implying that individuals with FMS and depression may benefit most from interventions that aim to decrease lability and increase self-efficacy for the most challenging times.

KW - Depression

KW - Fibromyalgia

KW - Longitudinal

KW - Pain

KW - Self-efficacy

KW - Subgroups

UR - http://www.scopus.com/inward/record.url?scp=84879589773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879589773&partnerID=8YFLogxK

U2 - 10.3109/10582452.2013.797536

DO - 10.3109/10582452.2013.797536

M3 - Article

AN - SCOPUS:84879589773

VL - 21

SP - 113

EP - 125

JO - Journal of Musculoskeletal Pain

JF - Journal of Musculoskeletal Pain

SN - 1058-2452

IS - 2

ER -